ROYAL BANK OF CANADA - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 59 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0194
+12.1%
0.00%
Q2 2023$0173
+765.0%
0.00%
Q1 2023$020
+100.0%
0.00%
Q2 2022$0
-100.0%
10
-99.9%
0.00%
Q1 2022$9,000
-76.3%
7,189
-69.9%
0.00%
Q4 2021$38,000
-46.5%
23,909
+10.6%
0.00%
Q3 2021$71,000
-31.7%
21,619
+31.7%
0.00%
Q2 2021$104,000
+2500.0%
16,410
+720.5%
0.00%
Q1 2021$4,0002,0000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders